Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.20
0.09 (0.36%)
At close: Aug 15, 2025, 3:02 PM

Pfizer Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.04B 2.85B 416M 1.94B
Short-Term Investments
19.43B 9.84B 22.32B 29.13B
Long-Term Investments
2.23B 15.37B 15.07B 21.53B
Other Long-Term Assets
9.82B 12.47B 13.16B 7.68B
Receivables
14.78B 15.54B 14.53B 15.74B
Inventory
10.85B 10.19B 8.98B 9.06B
Other Current Assets
4.25B 4.91B 5.02B 3.82B
Total Current Assets
50.36B 43.33B 51.26B 59.69B
Property-Plant & Equipment
18.39B 18.94B 16.27B 14.88B
Goodwill & Intangibles
123.94B 132.68B 94.75B 74.35B
Total Long-Term Assets
163.04B 183.17B 145.94B 121.78B
Total Assets
213.4B 226.5B 197.21B 181.48B
Account Payables
5.63B 6.71B 6.81B 5.58B
Deferred Revenue
1.51B 2.7B 2.52B 3.07B
Short-Term Debt
6.95B 10.35B 2.93B 2.24B
Other Current Liabilities
23.56B 23.32B 25.98B 28.27B
Total Current Liabilities
42.99B 47.79B 42.14B 42.67B
Long-Term Debt
56.7B 60.5B 31.93B 34.76B
Other Long-Term Liabilities
23.08B 28.28B 26.2B 26.24B
Total Long-Term Liabilities
81.9B 89.42B 59.15B 61.34B
Total Liabilities
124.9B 137.21B 101.29B 104.01B
Total Debt
63.65B 70.84B 34.86B 37B
Common Stock
480M 478M 476M 473M
Retained Earnings
116.72B 118.35B 125.66B 103.39B
Comprehensive Income
-7.84B -7.96B -8.3B -5.9B
Shareholders Equity
88.2B 89.01B 95.66B 77.2B
Total Investments
21.66B 25.2B 37.38B 50.65B